Objectives - discussion on the journal article:

1. Learn about tofacitinib and its role as a new therapy for ankylosing spondylitis (AS).

2. Analyze and review the journal article provided.

3. Discuss the clinical role of using tofacitinib in our patients with AS.


Session date: 
12/19/2017 - 8:30am to 9:30am CST
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Josna Haritha, M.D.